We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Aic3.1
AICAR (Acadesine) Research
Mostly mechanism / observational
19 peer-reviewed studies
What the evidence says
Mostly mechanism / observational
Most AICAR (Acadesine) studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 1994–2026.
Based on 19 studies · 1 meta-analysis · 6 RCTs
Confidence
Moderate confidence
By outcome
Metabolic & AMPK
Mostly mechanism / observational9 studies
Cardiac surgery & ischemia (human)
Too few graded studies8 studies
Endurance & exercise (preclinical)Increased running endurance in sedentary mice as an AMPK "exercise mimetic"; no human exercise/performance evidence, poor oral bioavailability, and WADA-banned. · Not established
Mostly mechanism / observational3 studies
Safety profile
Too few graded studies1 study
Active research area
8 studies in the last 5 years · Latest meta-analysis: 1997
199420102026
1Meta-AnalysisCited 118×1997
Mangano DT · JAMA (1997)
No plain-language summary recorded for this citation — open the paper to read its abstract.
In plain English: This review aims to give an overview of the present knowledge on AMPK-dependent and AMPK-independent effects of AICAr on metabolism, hypoxia, exercise, nucleotide synthesis, and cancer, calling for caution in the interpretation of AICAr-based studies in the context of understanding AMPK signaling pathway.
Višnjić D et al. · Cells (2021)
The majority of early studies on the role of AMPK, both in the physiological regulation of metabolism and in cancer pathogenesis, were based solely on the use of AICAr as an AMPK-activator.
Even with more complex models of AMPK downregulation and knockout being introduced, AICAr remained a regular starting point for many studies focusing on AMPK biology.
However, there is an increasing number of studies showing that numerous AICAr effects, previously attributed to AMPK activation, are in fact AMPK-independent.
In plain English: The scope of this article is to review knowledge of the effect of purine nucleotide precursors such as D-ribose, AICAR, inosine, hypoxanthine, and adenine on myocardial ischemia-reperfusion injury and highlight potential targets for treating myocardial metabolic and mechanical dysfunction associated with ischemia-reperfusion injury by these molecules.
Musial PT et al. · International journal of molecular sciences (2025)
Depletion of cardiac nucleotides and compromised myocardial mechanical function are linked to both acute myocardial ischemia and decompensatory remodelling of the myocardium in heart failure.
Theoretically, in both acute ischemia and chronic high-demand situations associated with the development of heart failure, an imbalance in the breakdown, salvage, and synthesis of purine nucleotides results in a net loss of purine nucleotides.
It was found that the use of nucleotide precursors can be a potentially effective approach to diminishing ischemia-reperfusion damage.
In plain English: This provides a structural pharmacology foundation for developing targeted immunometabolic therapies to restore muscle regeneration in injury and degenerative diseases.
Liu R et al. · Biochemical pharmacology (2026)
The review outlines therapeutic strategies to reprogram macrophage function, spanning pharmacological agents (AMPK/PPARγ agonists, cytokine/chemokine modulation), nanotechnology, cell therapies (e.g., exosomes), and physical interventions.
A key feature is the integration of molecular docking analyses, revealing structural interactions between compounds (e.g., AICAR, Cenicriviroc) and targets like AMPK, PPARγ, CCR2, and CCR5.
This provides a structural pharmacology foundation for developing targeted immunometabolic therapies to restore muscle regeneration in injury and degenerative diseases.
In plain English: We also spotlighted the significant role of various signaling pathways, activators, and inhibitors of AMPK in serving as therapeutic strategies for anti-cancer and anti-aging therapy.
Penugurti V et al. · Seminars in cancer biology (2024)
Apart from these functions, AMPK plays a key role in orchestrating aging and aging-related disorders, including cardiovascular diseases (CVD), Osteoarthritis (OA), and Diabetes.
In this review article, we summarized the functions of AMPK pathway based on its oncogenic and tumor-suppressive roles and highlighted the importance of AMPK pathway in regulating cellular aging.
We also spotlighted the significant role of various signaling pathways, activators, and inhibitors of AMPK in serving as therapeutic strategies for anti-cancer and anti-aging therapy.
In plain English: This review aims to discuss the existing evidence supporting the therapeutic potential of AMPK activation in sepsis management.
Yumoto T et al. · Frontiers in endocrinology (2024)
Sepsis is a global health challenge marked by limited clinical options and high mortality rates.
AMP-activated protein kinase (AMPK) is a cellular energy sensor that mediates multiple crucial metabolic pathways that may be an attractive therapeutic target in sepsis.
This review aims to discuss the existing evidence supporting the therapeutic potential of AMPK activation in sepsis management.
In plain English: Such so-called exercise or caloric restriction 'mimetics' have so far mostly been described in pre-clinical, experimental settings with limited translation into humans.
Handschin C · Pharmacological Research (2016)
Review explicitly addressing whether exercise/caloric-restriction mimetics (including AICAR-class AMPK activators) are ready for human use
Concludes they remain largely preclinical with limited human translation — a direct caution against the 'exercise in a pill' framing
Most candidates converge on PGC-1α in skeletal muscle, the same pathway AICAR engages
In plain English: The most efficacious compounds that induce muscle hypertrophy or endurance are hampered by severe side effects and are classified as doping.
Weihrauch M, Handschin C · Biochemical Pharmacology (2018)
Review of 'exercise mimetics' including AICAR, weighing the AMPK–PGC-1α rationale against translational reality
Notes that the most potent muscle/endurance compounds carry severe side effects and are classified as doping (AICAR is WADA-banned)
Frames the feasibility of pharmacological exercise mimicry as highly debated, not established
In plain English: Stimuli-inducible GLUT4 release relies on Tbc1d1-evoking proximal stimuli, such as AICAR and intracellular Ca2+.
Hatakeyama H, Morino T, Ishii T, Kanzaki M · The Journal of Biological Chemistry (2019)
Mechanistic cell-based reconstitution study grounding the GLUT4/glucose-uptake arm of AICAR's action
AICAR acts as an exercise-mimetic stimulus that triggers GLUT4 release via the RabGAP Tbc1d1 (the contraction/AMPK pathway, distinct from insulin's AS160 route)
Clarifies how AMPK-type stimuli mobilize glucose transporters in muscle cells